Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study introduces a hypothesis that elevated DHT at puberty may cause chronic thermal stress in specific scalp areas, potentially explaining Androgenetic Alopecia characteristics and guiding future research.

This paper documents a case of natural reversal of moderate-to-severe androgenetic alopecia without medical intervention, but emphasizes it is an individual observation not generalizable to broader populations.

In this study, topical finasteride 0.25% showed sustained effectiveness over 52 weeks, especially in the frontotemporal areas of men with androgenetic alopecia, while maintaining an excellent safety profile.

This study developed consensus guidelines for the use of low-dose oral and topical minoxidil in male and female pattern hair loss, recommending specific doses, monitoring procedures, and timing of application around hair transplant surgeries.

In this randomized trial, bicalutamide was found to improve hair count and shaft diameter more than spironolactone in women with Female Pattern Hair Loss over 24 weeks, although no significant differences were observed in clinical endpoints between the two treatments.

This case report from Dr Batra’s Homeopathy Clinic documents a middle-aged man with trichotillomania who showed marked improvement in hair regrowth and reduced hair pulling after receiving a classical homeopathic treatment for seven months.

This study concluded that hair loss is a common issue after vertical sleeve gastrectomy, influenced by serum leucine concentration, and is not typically due to low iron or zinc levels.

In this documented case report, the researcher detailed a natural reversal of moderate-to-severe androgenetic alopecia without any medical interventions by systematically observing and analyzing hair regrowth over time, emphasizing that these findings are purely from personal practice and not applicable to broader populations.

This study conducted a meta-analysis and found that men with both frontal and vertex male pattern baldness have a slightly increased risk of developing prostate cancer, though most data was from Caucasian populations and effect modification by genetic variations was not assessed.

This phase II study found that a 0.05% topical dutasteride solution was more effective than oral finasteride (1 mg/day) in increasing hair count and width in males with androgenetic alopecia over 24 weeks, without causing irritation.

This review of 24 studies examined hair transplantation in women and found that while both genders experience significant psychosocial impacts from hair loss, women often face greater stigma and present different thinning patterns, requiring tailored surgical techniques and considerations.

Immune system changes may contribute to female pattern hair loss.

Hair diameter diversity helps assess hair loss, but its standard measure varies by individual and ethnicity.

This study found that topical minoxidil 5% remains the most common treatment for androgenic alopecia due to its high tolerability and patient satisfaction, but topical sildenafil 2% shows promise as an alternative, especially with positive hair thickness outcomes in certain areas.

This literature review suggests that oral minoxidil may improve tolerability compared to its topical form for treating androgenetic alopecia, although individual treatment plans are necessary due to differing side effects and response patterns.

This randomized, double-blind, placebo-controlled phase III trial found that a 24-week treatment with topical finasteride significantly increased hair growth and was well-tolerated in Chinese men with androgenetic alopecia compared to placebo.

This study found that combining PRP with topical minoxidil or finasteride significantly improved hair density and thickness, with patient satisfaction highest for multiple treatment combinations and longer durations.

The authors suggest that during hair transplantation for hair loss, the parietal eminence area should be prioritized along with the mid-scalp to address future noticeable thinning, especially since this area often becomes more conspicuous over time.

In this research, a thorough review of hair loss issues and treatments identified the effectiveness of minoxidil and finasteride for alopecia in the scalp's vertex region, but noted concerns about their potential long-term effects, leading to increased interest in herbal therapies.

In this retrospective analysis, dutasteride mesotherapy was used in 10 patients with androgenetic alopecia and resulted in hair density and width changes measured at the scalp, but specific efficacy results are not detailed in the abstract.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

This study found that Latina girls with a unique form of alopecia areata had small, confetti-like hair loss macules that resolved spontaneously within months, suggesting a distinct variant from classic alopecia areata.

This study found that using a specific ratio method based on the patient's scalp measurements can effectively predict the dimensions of the permanent safe zone for hair transplants, particularly in early stages of androgenetic alopecia, potentially ensuring long-lasting transplant results.

In this study, injections of PRP and MZT products significantly improved hair thickness, density, and count in AGA patients over six months, with variability observed in the extent of improvement between different formulations.

In this study, patients with androgenetic alopecia who received type A botulinum toxin treatment showed increased follicle width and length at the vertex and left frontal area over three months, but no significant changes in follicle or hair count compared to the control group.

In this study, dutasteride was found to be effective and safe in treating androgenetic alopecia in men who did not respond to finasteride, with improvements observed in hair loss and quality over 24 weeks.

In this randomized clinical trial, oral minoxidil was not superior to topical minoxidil in increasing hair density in men with androgenetic alopecia over 24 weeks, though photographic analysis suggested oral minoxidil may work better on the vertex area of the scalp.

This study suggests that lichen planopilaris should be considered as a potential diagnosis in African American women with scarring alopecia, often displaying an "arrowhead" distribution pattern, which may guide treatment strategies.

In this study, researchers reported that intradermal injections of Dr. SKS hair booster serum improved hair growth and patient satisfaction in individuals experiencing COVID-19-induced persistent telogen effluvium, with increased benefits observed over six months.

This meta-analysis found that men with vertex balding at age 40 or older may have a modestly increased risk of prostate cancer, with a pooled relative risk of 1.08, but no significant association was observed with frontal balding.